Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GBE1 Antikörper (AA 101-200) (Cy5)

GBE1 Reaktivität: Human WB, IF (cc), IF (p) Wirt: Kaninchen Polyclonal Cy5
Produktnummer ABIN1703928
  • Target Alle GBE1 Antikörper anzeigen
    GBE1 (Glucan (1,4-alpha-), Branching Enzyme 1 (GBE1))
    Bindungsspezifität
    • 14
    • 7
    • 7
    • 6
    • 6
    • 5
    • 4
    • 1
    • 1
    • 1
    • 1
    AA 101-200
    Reaktivität
    • 44
    • 11
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 38
    • 6
    Kaninchen
    Klonalität
    • 41
    • 3
    Polyklonal
    Konjugat
    • 18
    • 4
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser GBE1 Antikörper ist konjugiert mit Cy5
    Applikation
    • 41
    • 21
    • 15
    • 12
    • 12
    • 6
    • 4
    • 4
    • 4
    • 3
    • 3
    • 1
    Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
    Homologie
    Human,Mouse,Rat,Rabbit
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human GBE1
    Isotyp
    IgG
    Top Product
    Discover our top product GBE1 Primärantikörper
  • Applikationshinweise
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Haltbarkeit
    12 months
  • Target
    GBE1 (Glucan (1,4-alpha-), Branching Enzyme 1 (GBE1))
    Andere Bezeichnung
    GBE1 (GBE1 Produkte)
    Synonyme
    glgBII antikoerper, APBD antikoerper, GBE antikoerper, GSD4 antikoerper, 2310045H19Rik antikoerper, 2810426P10Rik antikoerper, D16Ertd536e antikoerper, 1,4-alpha-glucan branching protein GlgB antikoerper, 1,4-alpha-glucan branching protein antikoerper, glycogen branching protein antikoerper, glycogen branching enzyme antikoerper, 1,4-alpha-glucan-branching protein antikoerper, glycogen branching enzyme; BE; 1,4-alpha-D-glucan:1,4-alpha-D-glucan 6-glucosyl-transferase antikoerper, 1,4-alpha-glucan branching enzyme 1 antikoerper, glucan (1,4-alpha-), branching enzyme 1 antikoerper, glgB antikoerper, ECs4277 antikoerper, SCO7332 antikoerper, Synpcc7942_1085 antikoerper, AZC_4116 antikoerper, Sros_8169 antikoerper, Despr_0975 antikoerper, GBE1 antikoerper, Gbe1 antikoerper
    Hintergrund

    Synonyms: 1,4 alpha glucan branching enzyme, 4-alpha-glucan-branching enzyme, amylo 1,4 to 1,6 transglucosidase, amylo 1,4 to 1,6 transglycosylase, Andersen disease, Brancher enzyme, GBE 1, GBE, GBE1, gGlucan 1,4 alpha , branching enzyme 1, GLGB_HUMAN, Glucan 1,4 alpha branching enzyme, Glycogen branching enzyme, Glycogen storage disease type IV, Glycogen-branching enzyme, OTTHUMP00000213788, OTTHUMP00000213833.

    Background: GBE1 is a 702 amino acid protein that is expressed at high levels in muscle and liver and is involved in glycogen biosynthesis. Existing as a monomer, GBE1 catalyzes the transfer of alpha-1,4-linked glucosyl units from the outer end of a glycogen chain to an alpha-1,6 position on a neighboring glycogen chain and, via this catalytic activity, plays an essential role in glycogen accumulation. Defects in the gene encoding GBE1 are the cause of glycogen storage disease type 4 (GSD4) and adult polyglucosan body disease (APBD), the first of which is a metabolic disorder that is associated with the accumulation of polysaccharides and is characterized by liver disease during childhood. Unlike GSD4, APBD is a late-onset disorder that affects the central and peripheral nervous systems and is characterized by cognitive impairment, pyramidal tetraparesis and peripheral neuropathy.

    Gen-ID
    2632
    Pathways
    Cellular Glucan Metabolic Process
Sie sind hier:
Kundenservice